v2.4.0.6
Acquisitions, Investments, and Licenses (Tables)
|
3 Months Ended |
|
Business Acquisition [Line Items] |
|
Pro Forma Result of Combined Companies |
C:
C:
C:
|
|
|
|
|
|
|
|
|
|
|
For the three months ended March
31, |
|
(In thousands)
|
|
2013 |
|
|
2012 |
|
C:
C:
Revenues
|
|
$ |
31,376 |
|
|
$ |
10,958 |
|
Net loss
|
|
$ |
(35,276 |
) |
|
$ |
(9,210 |
) |
Net loss attributable to common shareholders
|
|
$ |
(35,149 |
) |
|
$ |
(9,766 |
) |
Basic and diluted loss per share
|
|
$ |
(0.11 |
) |
|
$ |
(0.03 |
) |
C:
|
Maximum exposure of unconsolidated investments |
C:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in thousands)
Investee name
|
|
Year invested |
|
|
Accounting method
|
|
Ownership at March
31, 2013 |
|
|
Investment |
|
|
Underlying equity in net assets |
|
|
Closing share price at March 31, 2013 for investments available for sale |
|
Sorrento
|
|
|
2009 |
|
|
Equity method |
|
|
20 |
% |
|
$ |
2,300 |
|
|
$ |
1,219 |
|
|
|
|
|
Cocrystal
|
|
|
2009 |
|
|
Equity method |
|
|
16 |
% |
|
|
2,500 |
|
|
|
675 |
|
|
|
|
|
Neovasc
|
|
|
2011 |
|
|
Equity method, warrants available for sale |
|
|
4 |
% |
|
|
2,013 |
|
|
|
287 |
|
|
|
|
|
Fabrus
|
|
|
2010 |
|
|
VIE, equity method |
|
|
13 |
% |
|
|
650 |
|
|
|
(28 |
) |
|
|
|
|
BZNE common stock
|
|
|
2012 |
|
|
VIE, equity method |
|
|
12 |
% |
|
|
1,276 |
|
|
|
(302 |
) |
|
|
|
|
RXi
|
|
|
2013 |
|
|
Equity method |
|
|
21 |
% |
|
|
15,000 |
|
|
|
3,766 |
|
|
|
|
|
TESARO
|
|
|
2010 |
|
|
Investment available for sale |
|
|
1 |
% |
|
|
550 |
|
|
|
|
|
|
|
$21.96 |
|
Neovasc options
|
|
|
2011 |
|
|
Investment available for sale |
|
|
N/A |
|
|
|
925 |
|
|
|
|
|
|
|
CA$ 2.60 |
|
BZNE Note and conversion feature
|
|
|
2012 |
|
|
VIE, investment available for sale |
|
|
N/A |
|
|
|
1,700 |
|
|
|
|
|
|
|
|
|
ChromaDex
|
|
|
2012 |
|
|
Investment available for sale |
|
|
1 |
% |
|
|
1,320 |
|
|
|
|
|
|
|
$ 0.71 |
|
Plus unrealized gains on investments, options and warrants, net
|
|
|
|
8,920 |
|
|
|
|
|
|
|
|
|
Less accumulated losses in investees
|
|
|
|
(8,608 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total carrying value of equity method investees and investments, available for sale
|
|
|
$ |
28,546 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cytochroma acquisition [Member]
|
|
Business Acquisition [Line Items] |
|
Estimated fair value of the net assets acquired and liabilities assumed in the acquisition of at the date of acquisition |
C:
|
|
|
|
|
(In thousands)
|
|
|
|
Current assets (including cash of $378 thousand)
|
|
$ |
1,224 |
|
Intangible assets:
|
|
|
|
|
In-process research and development
|
|
|
191,530 |
|
Patents
|
|
|
210 |
|
|
|
|
|
|
Total intangible assets
|
|
|
191,740 |
|
Goodwill
|
|
|
2,411 |
|
Plant and equipment
|
|
|
306 |
|
Accounts payable and accrued expenses
|
|
|
(1,069 |
) |
|
|
|
|
|
Total purchase price
|
|
$ |
194,612 |
|
|
|
|
|
|
|
SciGen [Member]
|
|
Business Acquisition [Line Items] |
|
Summary of consolidated assets and non-recourse liabilities related to SciGen |
C:
|
|
|
|
|
|
|
|
|
(In thousands)
|
|
March 31, 2013 |
|
|
December 31, 2012 |
|
Assets
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
301 |
|
|
$ |
174 |
|
Accounts receivable, net
|
|
|
76 |
|
|
|
387 |
|
Inventories, net
|
|
|
1,399 |
|
|
|
1,092 |
|
Prepaid expenses and other current assets
|
|
|
174 |
|
|
|
199 |
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
1,950 |
|
|
|
1,852 |
|
Property, plant and equipment, net
|
|
|
1,493 |
|
|
|
1,539 |
|
Intangible assets, net
|
|
|
1,150 |
|
|
|
1,154 |
|
Goodwill
|
|
|
815 |
|
|
|
796 |
|
Other assets
|
|
|
324 |
|
|
|
231 |
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
5,732 |
|
|
|
5,572 |
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$ |
1,220 |
|
|
$ |
1,108 |
|
Accrued expenses
|
|
|
3,352 |
|
|
|
2,859 |
|
Notes payable
|
|
|
1,329 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
5,901 |
|
|
|
3,967 |
|
Other long-term liabilities
|
|
|
288 |
|
|
|
1,529 |
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
$ |
6,189 |
|
|
$ |
5,496 |
|
|
|
|
|
|
|
|
|
|
|
X |
- Definition
Pro forma result of combined companies.
+ References+ Details
Name: |
opk_ProFormaResultOfCombinedCompaniesTableTextBlock |
Namespace Prefix: |
opk_ |
Data Type: |
nonnum:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_BusinessAcquisitionLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
Tabular disclosure of investment income derived from investments in debt and equity securities consisting of interest income earned from investments in debt securities and on cash and cash equivalents, dividend income from investments in equity securities, and income or expense derived from the amortization of investment related discounts or premiums, respectively. This item does not include realized or unrealized gains or losses on the sale or holding of investments in debt and equity securities required to be included in earnings for the period or for other than temporary losses related to investments in debt and equity securities which are included in realized losses in the period recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS115-1/124-1
-Paragraph 13, 14, 15, 16
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 115
-Paragraph 14, 16
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.8)
-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688
Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.9)
-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688
Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7(a),(b))
-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688
+ Details
Name: |
us-gaap_InvestmentIncomeTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
nonnum:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
Tabular disclosure of all of the fair values of the purchase price and assets and liabilities acquired in a business combination.
+ References+ Details
Name: |
us-gaap_ScheduleOfPurchasePriceAllocationTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
nonnum:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 4
-Subparagraph g
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 140
-Paragraph 35
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Paragraph 22B
-Appendix D
Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 5A
-URI http://asc.fasb.org/extlink&oid=7880789&loc=SL6759159-111685
Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS140-4/FIN46(R)-8
-Paragraph C4
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Paragraph 22E
-Appendix D
Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=7880789&loc=d3e5747-111685
Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Paragraph 24
-Appendix D
Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7880789&loc=d3e5710-111685
Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 2, 14, 15, 16, 23, 24, 25, 26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Paragraph 23A
-Appendix D
Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=7880789&loc=SL6228884-111685
Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7880789&loc=d3e5728-111685
Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Variable Interest Entity
-URI http://asc.fasb.org/extlink&oid=6528138
+ Details
Name: |
us-gaap_ScheduleOfVariableInterestEntitiesTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
nonnum:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
|